Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC.

2017


Piramal Enterprises Completes the Acquisition of a Portfolio of Drugs for Spasticity and Pain Management from Mallinckrodt LLC.

Piramal Realty marks exclusive pre-Launch of Piramal Revanta

2017


Piramal Realty marks exclusive pre-Launch of Piramal Revanta

Piramal Enterprises Limited and Ivanhoé Cambridge announce Partnership to Invest in Residential Developments in India

2017


Piramal Enterprises Limited and Ivanhoé Cambridge announce Partnership to Invest in Residential Developments in India

Piramal Enterprises Limited announces its plan to enter Housing Finance

2017


Piramal Enterprises Limited announces its plan to enter Housing Finance

Piramal Fund Management launches an Innovative Flexi Lease Rental Discounting (LRD) for Commercial Assets.

2016


Piramal Fund Management launches an Innovative Flexi Lease Rental Discounting (LRD) for Commercial Assets.

Piramal Enterprises Critical Care Division expands its product portfolio; enters into an agreement to acquire Janssen's Injectable Anaesthesia and Pain Management products

2016


Piramal Enterprises Critical Care Division expands its product portfolio; enters into an agreement to acquire Janssen's Injectable Anaesthesia and Pain Management products

Piramal Enterprises Limited and Bain Capital Credit to pursue distressed debt investing in India

2016


Piramal Enterprises Limited and Bain Capital Credit to pursue distressed debt investing in India

Piramal Enterprises enters into an agreement to acquire Ash Stevens Inc., a US based Contract and Drug Manufacturing Orgnisation (CDMO) for High Potency APIs (HPAPIs)

2016


Piramal Enterprises enters into an agreement to acquire Ash Stevens Inc., a US based Contract and Drug Manufacturing Orgnisation (CDMO) for High Potency APIs (HPAPIs)

Piramal Realty forays into commercial real estate with the launch of Piramal Agastya Corporate Park in Kurla, Mumbai

2016


Piramal Realty forays into commercial real estate with the launch of Piramal Agastya Corporate Park in Kurla, Mumbai

Piramal Enterprises enters an agreement to acquire four brands from Pfizer Limited for its Consumer Products Business

2016


Piramal Enterprises enters an agreement to acquire four brands from Pfizer Limited for its Consumer Products Business

Piramal Realty launches its signature project, Piramal Aranya in Byculla, Mumbai

2016


Piramal Realty launches its signature project, Piramal Aranya in Byculla, Mumbai

Piramal Enterprises announces the sale of its Canada-based cartilage repair product, BST-CarGel® to Smith & Nephew

2016


Piramal Enterprises announces the sale of its Canada-based cartilage repair product, BST-CarGel® to Smith & Nephew

Piramal Enterprises acquires five brands from Organon India Pvt. Ltd. (OIPL) and MSD BV for its Consumer Products Business.

2015


Piramal Enterprises acquires five brands from Organon India Pvt. Ltd. (OIPL) and MSD BV for its Consumer Products Business.

Piramal Enterprises acquires the Baby Care brand – Little’s for the Consumer Products Business

2015


Piramal Enterprises acquires the Baby Care brand – Little’s for the Consumer Products Business

Piramal Realty launches a new community for natural and holistic living at Balkum, Thane, Mumbai: Piramal Vaikunth

2015


Piramal Realty launches a new community for natural and holistic living at Balkum, Thane, Mumbai: Piramal Vaikunth

Piramal Realty secures $150 million (INR 900 crore) from Goldman Sachs

2015


Piramal Realty secures $150 million (INR 900 crore) from Goldman Sachs

Warburg Pincus to invest INR 1800cr in Piramal Realty

2015


Warburg Pincus to invest INR 1800cr in Piramal Realty

DRG has acquired Healthcare Business Insights (HBI), a trusted provider of best Practice research, training and services to more than 1,400 hospitals across the U.S.

2015


DRG has acquired Healthcare Business Insights (HBI), a trusted provider of best Practice research, training and services to more than 1,400 hospitals across the U.S.

Piramal Enterprises Ltd. acquires Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.

2015


Piramal Enterprises Ltd. acquires Kentucky based Specialty Pharmaceutical CDMO, Coldstream Laboratories Inc.

Decision Resources Group acquired Relay Technology Management. The acquisition adds new products and significant technological capabilities.

2014


Decision Resources Group acquired Relay Technology Management. The acquisition adds new products and significant technological capabilities.

Canada Pension Plan Investment Board (CPPIB) and Piramal Enterprises Limited announce a US$500 million Strategic Alliance for Residential Development Debt Financing in India; appoint Piramal Fund Management (at the time known as Indiareit) as advisor

2014


Canada Pension Plan Investment Board (CPPIB) and Piramal Enterprises Limited announce a US$500 million Strategic Alliance for Residential Development Debt Financing in India; appoint Piramal Fund Management (at the time known as Indiareit) as advisor

Piramal Enterprises Limited agrees to acquire an effective 20% equity stake in Shriram Capital Limited, a financial services company, for an aggregate consideration of INR 20.14 Billion

2014


Piramal Enterprises Limited agrees to acquire an effective 20% equity stake in Shriram Capital Limited, a financial services company, for an aggregate consideration of INR 20.14 Billion

Piramal Enterprises Limited acquires 9.99% equity stake in Shriram City Union Finance Limited

2014


Piramal Enterprises Limited acquires 9.99% equity stake in Shriram City Union Finance Limited

APG Asset Management, the Dutch pension fund asset manager and Piramal Enterprises Limited announce a strategic alliance for investing in rupee denominated mezzanine instruments issued by infrastructure companies in India with a target investment of US$1  billion, over the next 3 years

2014


APG Asset Management, the Dutch pension fund asset manager and Piramal Enterprises Limited announce a strategic alliance for investing in rupee denominated mezzanine instruments issued by infrastructure companies in India with a target investment of US$1 billion, over the next 3 years

Piramal Enterprises Ltd. consumer products' division acquires the brand CALADRYL® in India.

2013


Piramal Enterprises Ltd. consumer products' division acquires the brand CALADRYL® in India.

Piramal Water (Sarvajal) honoured with 'Enabling Technology Award of the Year 2013' by Frost & Sullivan

2013


Piramal Water (Sarvajal) honoured with 'Enabling Technology Award of the Year 2013' by Frost & Sullivan

Imaging division's lead radiopharmaceutical, Florbetaben, accepted for review by the US FDA and EMA for the visual detection of Beta-Amyloid in Alzheimer's disease

2013


Imaging division's lead radiopharmaceutical, Florbetaben, accepted for review by the US FDA and EMA for the visual detection of Beta-Amyloid in Alzheimer's disease

Piramal Enterprises Limited acquires Molecular Imaging Development portfolio of Bayer Pharma

2013


Piramal Enterprises Limited acquires Molecular Imaging Development portfolio of Bayer Pharma

Piramal Healthcare Limited is renamed to Piramal Enterprises Limited.

2012


Piramal Healthcare Limited is renamed to Piramal Enterprises Limited.

Piramal Realty, a privately owned real estate entity, was formed

2012


Piramal Realty, a privately owned real estate entity, was formed

Piramal Enterprises acquires health care information management firm, Decision Resources Group, USA for US$635  million

2012


Piramal Enterprises acquires health care information management firm, Decision Resources Group, USA for US$635 million

Piramal Enterprises starts a  Non-Banking Financial Company (NBFC) focused on lending to real estate, education and hospitals

2012


Piramal Enterprises starts a Non-Banking Financial Company (NBFC) focused on lending to real estate, education and hospitals

BST-CarGel, our innovative bio-orthopedic product for cartilage repair, receives European CE mark approval

2012


BST-CarGel, our innovative bio-orthopedic product for cartilage repair, receives European CE mark approval

Decision Resources Group acquires Abacus International, a UK based global market access solutions company for many of the world’s leading health care companies

2012


Decision Resources Group acquires Abacus International, a UK based global market access solutions company for many of the world’s leading health care companies

Piramal Realty wins the auction of the landmark Hindustan Unilever training centre at Worli Sea Face, Mumbai

2012


Piramal Realty wins the auction of the landmark Hindustan Unilever training centre at Worli Sea Face, Mumbai

Piramal's Pharma Solutions manufacturing site at Grangemouth, Scotland becomes the world’s first contract supplier at commercial scale for ADCs.

2011


Piramal's Pharma Solutions manufacturing site at Grangemouth, Scotland becomes the world’s first contract supplier at commercial scale for ADCs.

Fortune 500 ranks Piramal Healthcare in the top-50 largest corporations across India

2011


Fortune 500 ranks Piramal Healthcare in the top-50 largest corporations across India

Piramal Healthcare acquires Indiareit, a real estate focused investment trust with AUM of US$760 Million

2011


Piramal Healthcare acquires Indiareit, a real estate focused investment trust with AUM of US$760 Million

UN Conference on Trade and Development’s World Investment Report 2011 ranks Piramal Healthcare as No. 5 in the top 10 pharmaceutical contract manufacturers worldwide

2011


UN Conference on Trade and Development’s World Investment Report 2011 ranks Piramal Healthcare as No. 5 in the top 10 pharmaceutical contract manufacturers worldwide

Piramal Healthcare acquires 11% of Vodafone India

2011


Piramal Healthcare acquires 11% of Vodafone India

Piramal Realty acquires Mafatlal Mills in Byculla, Mumbai

2011


Piramal Realty acquires Mafatlal Mills in Byculla, Mumbai

Oxygen Bio-research is acquired by Piramal Enterprises and is part of the Pharmaceutical Solutions division

2011


Oxygen Bio-research is acquired by Piramal Enterprises and is part of the Pharmaceutical Solutions division

Bharat Serum and Vaccines Ltd – Anaesthetics business buyout by Piramal Enterprises Ltd.

2011


Bharat Serum and Vaccines Ltd – Anaesthetics business buyout by Piramal Enterprises Ltd.

Acquisition of iPill, an oral contraceptive brand, from Cipla.

2010


Acquisition of iPill, an oral contraceptive brand, from Cipla.

Piramal sells the diagnostics division to Super Religare Laboratories Ltd

2010


Piramal sells the diagnostics division to Super Religare Laboratories Ltd

Biosyntech, Inc., Canada is acquired by Piramal Enterprises Ltd., part of the Life Sciences vertical, Bio-Orthopedics division

2010


Biosyntech, Inc., Canada is acquired by Piramal Enterprises Ltd., part of the Life Sciences vertical, Bio-Orthopedics division

Minard International Inc. is acquired.

2009


Minard International Inc. is acquired.

RxEliteinc, the U.S. based inhalation anaesthetic gas distribution business, is acquired

2009


RxEliteinc, the U.S. based inhalation anaesthetic gas distribution business, is acquired

Nicholas Piramal India Limited renamed to Piramal Healthcare Limited.

2008


Nicholas Piramal India Limited renamed to Piramal Healthcare Limited.

Khandelwal Laboratories is acquired

2008


Khandelwal Laboratories is acquired

Scientists from Piramal led the first exploration by an Indian pharmaceutical company to develop drug leads from geographies like Antarctica.

2007


Scientists from Piramal led the first exploration by an Indian pharmaceutical company to develop drug leads from geographies like Antarctica.

Piramal Healthcare listed as global leader by S&P Global Challengers.

2006


Piramal Healthcare listed as global leader by S&P Global Challengers.

Pfizer's Morpeth UK facility acquired

2006


Pfizer's Morpeth UK facility acquired

Piramal Glass acquires a part of The Glass Group (erstwhile Wheaton Glass) in USA.

2005


Piramal Glass acquires a part of The Glass Group (erstwhile Wheaton Glass) in USA.

Avecia Pharmaceutical is acquired

2005


Avecia Pharmaceutical is acquired

Nicholas forges alliance with scientists from Imperial College of the UK to carry out research in the field of rheumatoid arthritis.

2004


Nicholas forges alliance with scientists from Imperial College of the UK to carry out research in the field of rheumatoid arthritis.

Global Bulk Drugs is acquired.

2003


Global Bulk Drugs is acquired.

Sarabhai Piramal is acquired

2003


Sarabhai Piramal is acquired

ICI Pharma is acquired.

2002


ICI Pharma is acquired.

Started collaborative research with Centre for Biochemical Technology in the field of gene technology.

2000


Started collaborative research with Centre for Biochemical Technology in the field of gene technology.

Rhone Poulenc India Limited is acquired

2000


Rhone Poulenc India Limited is acquired

Piramal Glass acquires Ceylon Company Ltd, Sri Lanka.

1999


Piramal Glass acquires Ceylon Company Ltd, Sri Lanka.

Acquired the research unit of Hoechst Marion Roussel (India) in Mumbai.

1998


Acquired the research unit of Hoechst Marion Roussel (India) in Mumbai.

NPIL entered into an agreement with Reckitt & Colman for joint marketing of the latter's OTC products in India.

1997


NPIL entered into an agreement with Reckitt & Colman for joint marketing of the latter's OTC products in India.

Entered into a product tie-up with F. Hoffman-La-Roche.

1996


Entered into a product tie-up with F. Hoffman-La-Roche.

Boehringer Mannheim is acquired

1996


Boehringer Mannheim is acquired

The bulk drug division of Sumitra Pharmaceutical and Chemicals Ltd. Hyderabad transferred to NPIL.

1995


The bulk drug division of Sumitra Pharmaceutical and Chemicals Ltd. Hyderabad transferred to NPIL.

A joint venture agreement was entered into with Satelec, France for dental care products

1994


A joint venture agreement was entered into with Satelec, France for dental care products

Piramal entered into a joint venture agreement with Allergan of U.S.A., the leading manufacturers of Ophthalmic products.

1993


Piramal entered into a joint venture agreement with Allergan of U.S.A., the leading manufacturers of Ophthalmic products.

Set up a second formulation plant at Pithampur in Madhya Pradesh with state-of-the-art manufacturing facilities.

1992


Set up a second formulation plant at Pithampur in Madhya Pradesh with state-of-the-art manufacturing facilities.

A new formulation plant at Pithampur in Madhya Pradesh is commissioned.

1991


A new formulation plant at Pithampur in Madhya Pradesh is commissioned.

Gujarat Glass is merged with the group company, Nicholas Piramal India Ltd

1990


Gujarat Glass is merged with the group company, Nicholas Piramal India Ltd

Acquired Nicholas Laboratories.

1988


Acquired Nicholas Laboratories.

Acquired Gujarat Glass

1984


Acquired Gujarat Glass

In the early 1980s a young Ajay Piramal takes the reins of the Piramal Group

1980


In the early 1980s a young Ajay Piramal takes the reins of the Piramal Group